These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32639370)

  • 1. Uncovering the analgesic effects of a pH-dependent mu-opioid receptor agonist using a model of nonevoked ongoing pain.
    Massaly N; Temp J; Machelska H; Stein C
    Pain; 2020 Dec; 161(12):2798-2804. PubMed ID: 32639370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors.
    Baamonde A; Menéndez L; González-Rodríguez S; Lastra A; Seitz V; Stein C; Machelska H
    Sci Rep; 2020 Oct; 10(1):18599. PubMed ID: 33122720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic effects of a novel pH-dependent μ-opioid receptor agonist in models of neuropathic and abdominal pain.
    Rodriguez-Gaztelumendi A; Spahn V; Labuz D; Machelska H; Stein C
    Pain; 2018 Nov; 159(11):2277-2284. PubMed ID: 29994988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of injury-induced tissue acidosis by a nonsteroidal analgesic attenuates antinociceptive effects of the pH-dependent opioid agonist NFEPP.
    Celik MÖ; Negrete R; Di Rosso R; Machelska H; Stein C
    Sci Rep; 2022 Sep; 12(1):15172. PubMed ID: 36071140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of G-protein activation, calcium currents and opioid receptor phosphorylation by the pH-dependent antinociceptive agonist NFEPP.
    Celik MÖ; Seitz V; Yergöz F; Dembla S; Blum NK; Schulz S; Stein C
    Front Mol Neurosci; 2023; 16():1171855. PubMed ID: 37251645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.
    Jiménez-Vargas NN; Yu Y; Jensen DD; Bok DD; Wisdom M; Latorre R; Lopez C; Jaramillo-Polanco JO; Degro C; Guzman-Rodriguez M; Tsang Q; Snow Z; Schmidt BL; Reed DE; Lomax AE; Margolis KG; Stein C; Bunnett NW; Vanner SJ
    Gut; 2022 Apr; 71(4):695-704. PubMed ID: 33785555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving acidic microenvironments during colitis provide selective analgesic targets for a pH-sensitive opioid.
    Degro CE; Jiménez-Vargas NN; Tsang Q; Yu Y; Guzman-Rodriguez M; Alizadeh E; Hurlbut D; Reed DE; Lomax AE; Stein C; Bunnett NW; Vanner SJ
    Pain; 2023 Nov; 164(11):2501-2515. PubMed ID: 37326658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fentanyl and the Fluorinated Fentanyl Derivative NFEPP Elicit Distinct Hydrogen-Bond Dynamics of the Opioid Receptor.
    Lešnik S; Bren U; Domratcheva T; Bondar AN
    J Chem Inf Model; 2023 Aug; 63(15):4732-4748. PubMed ID: 37498626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat.
    Whiteside GT; Harrison JE; Pearson MS; Chen Z; Fundytus ME; Rotshteyn Y; Turchin PI; Pomonis JD; Mark L; Walker K; Broglé KC
    J Pharmacol Exp Ther; 2004 Aug; 310(2):793-9. PubMed ID: 15054116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.
    Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
    Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice.
    Bruce DJ; Peterson CD; Kitto KF; Akgün E; Lazzaroni S; Portoghese PS; Fairbanks CA; Wilcox GL
    Anesthesiology; 2019 Sep; 131(3):649-663. PubMed ID: 31343460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
    Iwaszkiewicz KS; Hua S
    Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pK
    Edwards SR; Blough BE; Cowart K; Howell GH; Araujo AA; Haskell JP; Huskinson SL; Rowlett JK; Brackeen MF; Freeman KB
    Neuropharmacology; 2024 Sep; 255():110002. PubMed ID: 38754577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
    Ko MC; Tuchman JE; Johnson MD; Wiesenauer K; Woods JH
    Psychopharmacology (Berl); 2000 Feb; 148(2):180-5. PubMed ID: 10663433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
    Hua S; Cabot PJ
    Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.
    Shinohara A; Andoh T; Saiki I; Kuraishi Y
    Eur J Pharmacol; 2018 Aug; 833():275-282. PubMed ID: 29886241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
    Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
    J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Energy Function for Fentanyl-Based Opioid Pain Killers.
    Lešnik S; Hodošček M; Bren U; Stein C; Bondar AN
    J Chem Inf Model; 2020 Jul; 60(7):3566-3576. PubMed ID: 32491854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor signaling, analgesic and side effects induced by a computationally designed pH-dependent agonist.
    Spahn V; Del Vecchio G; Rodriguez-Gaztelumendi A; Temp J; Labuz D; Kloner M; Reidelbach M; Machelska H; Weber M; Stein C
    Sci Rep; 2018 Jun; 8(1):8965. PubMed ID: 29895890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad-spectrum analgesic efficacy of IBNtxA is mediated by exon 11-associated splice variants of the mu-opioid receptor gene.
    Wieskopf JS; Pan YX; Marcovitz J; Tuttle AH; Majumdar S; Pidakala J; Pasternak GW; Mogil JS
    Pain; 2014 Oct; 155(10):2063-70. PubMed ID: 25093831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.